Shopping Cart 0
Cart Subtotal
USD 0

Global Cancer Biologics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4880

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 7320

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 9760
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Cancer Biologic is a medicinal preparation created by a biological process, it is used to treatment and remission cancer symptoms.

Scope of the Report:

The global Cancer Biologics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Biologics.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Cancer Biologics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Biologics market by product type and applications/end industries.

Market Segment by Companies, this report covers

Roche

Novartis

Eli Lilly

Sanofi

Celgene

Pfizer

Bayer

Johnson & Johnson

Bristol-Myers Squibb

Merck

Amgen

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Monoclonal Antibodies

Vaccines

Cell and Gene Therapy

Others

Market Segment by Applications, can be divided into

Hospitals

Clinics

Others

READ MORE

Table Of Content

Scope

Table of Contents

1 Cancer Biologics Market Overview

1.1 Product Overview and Scope of Cancer Biologics

1.2 Classification of Cancer Biologics by Types

1.2.1 Global Cancer Biologics Revenue Comparison by Types (2019-2024)

1.2.2 Global Cancer Biologics Revenue Market Share by Types in 2018

1.2.3 Monoclonal Antibodies

1.2.4 Vaccines

1.2.5 Cell and Gene Therapy

1.2.6 Others

1.3 Global Cancer Biologics Market by Application

1.3.1 Global Cancer Biologics Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Global Cancer Biologics Market by Regions

1.4.1 Global Cancer Biologics Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Cancer Biologics Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Biologics Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Biologics Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Cancer Biologics Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Biologics Status and Prospect (2014-2024)

1.5 Global Market Size of Cancer Biologics (2014-2024)

2 Manufacturers Profiles

2.1 Roche

2.1.1 Business Overview

2.1.2 Cancer Biologics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Roche Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.2 Novartis

2.2.1 Business Overview

2.2.2 Cancer Biologics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Novartis Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.3 Eli Lilly

2.3.1 Business Overview

2.3.2 Cancer Biologics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Eli Lilly Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.4 Sanofi

2.4.1 Business Overview

2.4.2 Cancer Biologics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sanofi Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.5 Celgene

2.5.1 Business Overview

2.5.2 Cancer Biologics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Celgene Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.6 Pfizer

2.6.1 Business Overview

2.6.2 Cancer Biologics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Pfizer Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.7 Bayer

2.7.1 Business Overview

2.7.2 Cancer Biologics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Bayer Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.8 Johnson & Johnson

2.8.1 Business Overview

2.8.2 Cancer Biologics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Johnson & Johnson Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.9 Bristol-Myers Squibb

2.9.1 Business Overview

2.9.2 Cancer Biologics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Bristol-Myers Squibb Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.10 Merck

2.10.1 Business Overview

2.10.2 Cancer Biologics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Merck Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.11 Amgen

2.11.1 Business Overview

2.11.2 Cancer Biologics Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Amgen Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

3 Global Cancer Biologics Market Competition, by Players

3.1 Global Cancer Biologics Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Cancer Biologics Players Market Share

3.2.2 Top 10 Cancer Biologics Players Market Share

3.3 Market Competition Trend

4 Global Cancer Biologics Market Size by Regions

4.1 Global Cancer Biologics Revenue and Market Share by Regions

4.2 North America Cancer Biologics Revenue and Growth Rate (2014-2019)

4.3 Europe Cancer Biologics Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Cancer Biologics Revenue and Growth Rate (2014-2019)

4.5 South America Cancer Biologics Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Cancer Biologics Revenue and Growth Rate (2014-2019)

5 North America Cancer Biologics Revenue by Countries

5.1 North America Cancer Biologics Revenue by Countries (2014-2019)

5.2 USA Cancer Biologics Revenue and Growth Rate (2014-2019)

5.3 Canada Cancer Biologics Revenue and Growth Rate (2014-2019)

5.4 Mexico Cancer Biologics Revenue and Growth Rate (2014-2019)

6 Europe Cancer Biologics Revenue by Countries

6.1 Europe Cancer Biologics Revenue by Countries (2014-2019)

6.2 Germany Cancer Biologics Revenue and Growth Rate (2014-2019)

6.3 UK Cancer Biologics Revenue and Growth Rate (2014-2019)

6.4 France Cancer Biologics Revenue and Growth Rate (2014-2019)

6.5 Russia Cancer Biologics Revenue and Growth Rate (2014-2019)

6.6 Italy Cancer Biologics Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Cancer Biologics Revenue by Countries

7.1 Asia-Pacific Cancer Biologics Revenue by Countries (2014-2019)

7.2 China Cancer Biologics Revenue and Growth Rate (2014-2019)

7.3 Japan Cancer Biologics Revenue and Growth Rate (2014-2019)

7.4 Korea Cancer Biologics Revenue and Growth Rate (2014-2019)

7.5 India Cancer Biologics Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Cancer Biologics Revenue and Growth Rate (2014-2019)

8 South America Cancer Biologics Revenue by Countries

8.1 South America Cancer Biologics Revenue by Countries (2014-2019)

8.2 Brazil Cancer Biologics Revenue and Growth Rate (2014-2019)

8.3 Argentina Cancer Biologics Revenue and Growth Rate (2014-2019)

8.4 Colombia Cancer Biologics Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Cancer Biologics by Countries

9.1 Middle East and Africa Cancer Biologics Revenue by Countries (2014-2019)

9.2 Saudi Arabia Cancer Biologics Revenue and Growth Rate (2014-2019)

9.3 UAE Cancer Biologics Revenue and Growth Rate (2014-2019)

9.4 Egypt Cancer Biologics Revenue and Growth Rate (2014-2019)

9.5 Nigeria Cancer Biologics Revenue and Growth Rate (2014-2019)

9.6 South Africa Cancer Biologics Revenue and Growth Rate (2014-2019)

10 Global Cancer Biologics Market Segment by Type

10.1 Global Cancer Biologics Revenue and Market Share by Type (2014-2019)

10.2 Global Cancer Biologics Market Forecast by Type (2019-2024)

10.3 Monoclonal Antibodies Revenue Growth Rate (2014-2024)

10.4 Vaccines Revenue Growth Rate (2014-2024)

10.5 Cell and Gene Therapy Revenue Growth Rate (2014-2024)

10.6 Others Revenue Growth Rate (2014-2024)

11 Global Cancer Biologics Market Segment by Application

11.1 Global Cancer Biologics Revenue Market Share by Application (2014-2019)

11.2 Cancer Biologics Market Forecast by Application (2019-2024)

11.3 Hospitals Revenue Growth (2014-2019)

11.4 Clinics Revenue Growth (2014-2019)

11.5 Others Revenue Growth (2014-2019)

12 Global Cancer Biologics Market Size Forecast (2019-2024)

12.1 Global Cancer Biologics Market Size Forecast (2019-2024)

12.2 Global Cancer Biologics Market Forecast by Regions (2019-2024)

12.3 North America Cancer Biologics Revenue Market Forecast (2019-2024)

12.4 Europe Cancer Biologics Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Cancer Biologics Revenue Market Forecast (2019-2024)

12.6 South America Cancer Biologics Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Cancer Biologics Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Cancer Biologics Picture

Table Product Specifications of Cancer Biologics

Table Global Cancer Biologics and Revenue (Million USD) Market Split by Product Type

Figure Global Cancer Biologics Revenue Market Share by Types in 2018

Figure Monoclonal Antibodies Picture

Figure Vaccines Picture

Figure Cell and Gene Therapy Picture

Figure Others Picture

Table Global Cancer Biologics Revenue (Million USD) by Application (2014-2024)

Figure Cancer Biologics Revenue Market Share by Applications in 2018

Figure Hospitals Picture

Figure Clinics Picture

Figure Others Picture

Table Global Market Cancer Biologics Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Cancer Biologics Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Cancer Biologics Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Cancer Biologics Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Cancer Biologics Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Cancer Biologics Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Cancer Biologics Revenue (Million USD) and Growth Rate (2014-2024)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Cancer Biologics Type and Applications

Table Roche Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Cancer Biologics Type and Applications

Table Novartis Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Eli Lilly Basic Information, Manufacturing Base and Competitors

Table Eli Lilly Cancer Biologics Type and Applications

Table Eli Lilly Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Cancer Biologics Type and Applications

Table Sanofi Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Celgene Basic Information, Manufacturing Base and Competitors

Table Celgene Cancer Biologics Type and Applications

Table Celgene Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Cancer Biologics Type and Applications

Table Pfizer Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Bayer Basic Information, Manufacturing Base and Competitors

Table Bayer Cancer Biologics Type and Applications

Table Bayer Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Cancer Biologics Type and Applications

Table Johnson & Johnson Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors

Table Bristol-Myers Squibb Cancer Biologics Type and Applications

Table Bristol-Myers Squibb Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Cancer Biologics Type and Applications

Table Merck Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Cancer Biologics Type and Applications

Table Amgen Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Global Cancer Biologics Revenue (Million USD) by Players (2014-2019)

Table Global Cancer Biologics Revenue Share by Players (2014-2019)

Figure Global Cancer Biologics Revenue Share by Players in 2017

Figure Global Cancer Biologics Revenue Share by Players in 2018

Figure Global Top 5 Players Cancer Biologics Revenue Market Share in 2018

Figure Global Top 10 Players Cancer Biologics Revenue Market Share in 2018

Figure Global Cancer Biologics Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Cancer Biologics Revenue (Million USD) by Regions (2014-2019)

Table Global Cancer Biologics Revenue Market Share by Regions (2014-2019)

Figure Global Cancer Biologics Revenue Market Share by Regions (2014-2019)

Figure Global Cancer Biologics Revenue Market Share by Regions in 2018

Figure North America Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Europe Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure South America Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Cancer Biologics Revenue and Growth Rate (2014-2019)

Table North America Cancer Biologics Revenue by Countries (2014-2019)

Table North America Cancer Biologics Revenue Market Share by Countries (2014-2019)

Figure North America Cancer Biologics Revenue Market Share by Countries (2014-2019)

Figure North America Cancer Biologics Revenue Market Share by Countries in 2018

Figure USA Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Canada Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Mexico Cancer Biologics Revenue and Growth Rate (2014-2019)

Table Europe Cancer Biologics Revenue (Million USD) by Countries (2014-2019)

Figure Europe Cancer Biologics Revenue Market Share by Countries (2014-2019)

Figure Europe Cancer Biologics Revenue Market Share by Countries in 2018

Figure Germany Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure UK Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure France Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Russia Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Italy Cancer Biologics Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Cancer Biologics Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Cancer Biologics Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Cancer Biologics Revenue Market Share by Countries in 2018

Figure China Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Japan Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Korea Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure India Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Cancer Biologics Revenue and Growth Rate (2014-2019)

Table South America Cancer Biologics Revenue by Countries (2014-2019)

Table South America Cancer Biologics Revenue Market Share by Countries (2014-2019)

Figure South America Cancer Biologics Revenue Market Share by Countries (2014-2019)

Figure South America Cancer Biologics Revenue Market Share by Countries in 2018

Figure Brazil Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Argentina Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Colombia Cancer Biologics Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Cancer Biologics Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Cancer Biologics Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Cancer Biologics Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Cancer Biologics Revenue Market Share by Countries in 2018

Figure Saudi Arabia Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure UAE Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Egypt Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Nigeria Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure South Africa Cancer Biologics Revenue and Growth Rate (2014-2019)

Table Global Cancer Biologics Revenue (Million USD) by Type (2014-2019)

Table Global Cancer Biologics Revenue Share by Type (2014-2019)

Figure Global Cancer Biologics Revenue Share by Type (2014-2019)

Figure Global Cancer Biologics Revenue Share by Type in 2018

Table Global Cancer Biologics Revenue Forecast by Type (2019-2024)

Figure Global Cancer Biologics Market Share Forecast by Type (2019-2024)

Figure Global Monoclonal Antibodies Revenue Growth Rate (2014-2019)

Figure Global Vaccines Revenue Growth Rate (2014-2019)

Figure Global Cell and Gene Therapy Revenue Growth Rate (2014-2019)

Figure Global Others Revenue Growth Rate (2014-2019)

Table Global Cancer Biologics Revenue by Application (2014-2019)

Table Global Cancer Biologics Revenue Share by Application (2014-2019)

Figure Global Cancer Biologics Revenue Share by Application (2014-2019)

Figure Global Cancer Biologics Revenue Share by Application in 2018

Table Global Cancer Biologics Revenue Forecast by Application (2019-2024)

Figure Global Cancer Biologics Market Share Forecast by Application (2019-2024)

Figure Global Hospitals Revenue Growth Rate (2014-2019)

Figure Global Clinics Revenue Growth Rate (2014-2019)

Figure Global Others Revenue Growth Rate (2014-2019)

Figure Global Cancer Biologics Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Cancer Biologics Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Cancer Biologics Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Cancer Biologics Revenue Market Forecast (2019-2024)

Figure Europe Cancer Biologics Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Cancer Biologics Revenue Market Forecast (2019-2024)

Figure South America Cancer Biologics Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Cancer Biologics Revenue Market Forecast (2019-2024)

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Roche

Novartis

Eli Lilly

Sanofi

Celgene

Pfizer

Bayer

Johnson & Johnson

Bristol-Myers Squibb

Merck

Amgen

Cancer Biologic is a medicinal preparation created by a biological process, it is used to treatment and remission cancer symptoms.

Scope of the Report:

The global Cancer Biologics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Biologics.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Cancer Biologics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Biologics market by product type and applications/end industries.

Market Segment by Companies, this report covers

Roche

Novartis

Eli Lilly

Sanofi

Celgene

Pfizer

Bayer

Johnson & Johnson

Bristol-Myers Squibb

Merck

Amgen

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Monoclonal Antibodies

Vaccines

Cell and Gene Therapy

Others

Market Segment by Applications, can be divided into

Hospitals

Clinics

Others

READ MORE

Scope

Table of Contents

1 Cancer Biologics Market Overview

1.1 Product Overview and Scope of Cancer Biologics

1.2 Classification of Cancer Biologics by Types

1.2.1 Global Cancer Biologics Revenue Comparison by Types (2019-2024)

1.2.2 Global Cancer Biologics Revenue Market Share by Types in 2018

1.2.3 Monoclonal Antibodies

1.2.4 Vaccines

1.2.5 Cell and Gene Therapy

1.2.6 Others

1.3 Global Cancer Biologics Market by Application

1.3.1 Global Cancer Biologics Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Global Cancer Biologics Market by Regions

1.4.1 Global Cancer Biologics Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Cancer Biologics Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Biologics Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Biologics Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Cancer Biologics Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Biologics Status and Prospect (2014-2024)

1.5 Global Market Size of Cancer Biologics (2014-2024)

2 Manufacturers Profiles

2.1 Roche

2.1.1 Business Overview

2.1.2 Cancer Biologics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Roche Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.2 Novartis

2.2.1 Business Overview

2.2.2 Cancer Biologics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Novartis Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.3 Eli Lilly

2.3.1 Business Overview

2.3.2 Cancer Biologics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Eli Lilly Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.4 Sanofi

2.4.1 Business Overview

2.4.2 Cancer Biologics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sanofi Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.5 Celgene

2.5.1 Business Overview

2.5.2 Cancer Biologics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Celgene Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.6 Pfizer

2.6.1 Business Overview

2.6.2 Cancer Biologics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Pfizer Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.7 Bayer

2.7.1 Business Overview

2.7.2 Cancer Biologics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Bayer Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.8 Johnson & Johnson

2.8.1 Business Overview

2.8.2 Cancer Biologics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Johnson & Johnson Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.9 Bristol-Myers Squibb

2.9.1 Business Overview

2.9.2 Cancer Biologics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Bristol-Myers Squibb Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.10 Merck

2.10.1 Business Overview

2.10.2 Cancer Biologics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Merck Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

2.11 Amgen

2.11.1 Business Overview

2.11.2 Cancer Biologics Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Amgen Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

3 Global Cancer Biologics Market Competition, by Players

3.1 Global Cancer Biologics Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Cancer Biologics Players Market Share

3.2.2 Top 10 Cancer Biologics Players Market Share

3.3 Market Competition Trend

4 Global Cancer Biologics Market Size by Regions

4.1 Global Cancer Biologics Revenue and Market Share by Regions

4.2 North America Cancer Biologics Revenue and Growth Rate (2014-2019)

4.3 Europe Cancer Biologics Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Cancer Biologics Revenue and Growth Rate (2014-2019)

4.5 South America Cancer Biologics Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Cancer Biologics Revenue and Growth Rate (2014-2019)

5 North America Cancer Biologics Revenue by Countries

5.1 North America Cancer Biologics Revenue by Countries (2014-2019)

5.2 USA Cancer Biologics Revenue and Growth Rate (2014-2019)

5.3 Canada Cancer Biologics Revenue and Growth Rate (2014-2019)

5.4 Mexico Cancer Biologics Revenue and Growth Rate (2014-2019)

6 Europe Cancer Biologics Revenue by Countries

6.1 Europe Cancer Biologics Revenue by Countries (2014-2019)

6.2 Germany Cancer Biologics Revenue and Growth Rate (2014-2019)

6.3 UK Cancer Biologics Revenue and Growth Rate (2014-2019)

6.4 France Cancer Biologics Revenue and Growth Rate (2014-2019)

6.5 Russia Cancer Biologics Revenue and Growth Rate (2014-2019)

6.6 Italy Cancer Biologics Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Cancer Biologics Revenue by Countries

7.1 Asia-Pacific Cancer Biologics Revenue by Countries (2014-2019)

7.2 China Cancer Biologics Revenue and Growth Rate (2014-2019)

7.3 Japan Cancer Biologics Revenue and Growth Rate (2014-2019)

7.4 Korea Cancer Biologics Revenue and Growth Rate (2014-2019)

7.5 India Cancer Biologics Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Cancer Biologics Revenue and Growth Rate (2014-2019)

8 South America Cancer Biologics Revenue by Countries

8.1 South America Cancer Biologics Revenue by Countries (2014-2019)

8.2 Brazil Cancer Biologics Revenue and Growth Rate (2014-2019)

8.3 Argentina Cancer Biologics Revenue and Growth Rate (2014-2019)

8.4 Colombia Cancer Biologics Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Cancer Biologics by Countries

9.1 Middle East and Africa Cancer Biologics Revenue by Countries (2014-2019)

9.2 Saudi Arabia Cancer Biologics Revenue and Growth Rate (2014-2019)

9.3 UAE Cancer Biologics Revenue and Growth Rate (2014-2019)

9.4 Egypt Cancer Biologics Revenue and Growth Rate (2014-2019)

9.5 Nigeria Cancer Biologics Revenue and Growth Rate (2014-2019)

9.6 South Africa Cancer Biologics Revenue and Growth Rate (2014-2019)

10 Global Cancer Biologics Market Segment by Type

10.1 Global Cancer Biologics Revenue and Market Share by Type (2014-2019)

10.2 Global Cancer Biologics Market Forecast by Type (2019-2024)

10.3 Monoclonal Antibodies Revenue Growth Rate (2014-2024)

10.4 Vaccines Revenue Growth Rate (2014-2024)

10.5 Cell and Gene Therapy Revenue Growth Rate (2014-2024)

10.6 Others Revenue Growth Rate (2014-2024)

11 Global Cancer Biologics Market Segment by Application

11.1 Global Cancer Biologics Revenue Market Share by Application (2014-2019)

11.2 Cancer Biologics Market Forecast by Application (2019-2024)

11.3 Hospitals Revenue Growth (2014-2019)

11.4 Clinics Revenue Growth (2014-2019)

11.5 Others Revenue Growth (2014-2019)

12 Global Cancer Biologics Market Size Forecast (2019-2024)

12.1 Global Cancer Biologics Market Size Forecast (2019-2024)

12.2 Global Cancer Biologics Market Forecast by Regions (2019-2024)

12.3 North America Cancer Biologics Revenue Market Forecast (2019-2024)

12.4 Europe Cancer Biologics Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Cancer Biologics Revenue Market Forecast (2019-2024)

12.6 South America Cancer Biologics Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Cancer Biologics Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Cancer Biologics Picture

Table Product Specifications of Cancer Biologics

Table Global Cancer Biologics and Revenue (Million USD) Market Split by Product Type

Figure Global Cancer Biologics Revenue Market Share by Types in 2018

Figure Monoclonal Antibodies Picture

Figure Vaccines Picture

Figure Cell and Gene Therapy Picture

Figure Others Picture

Table Global Cancer Biologics Revenue (Million USD) by Application (2014-2024)

Figure Cancer Biologics Revenue Market Share by Applications in 2018

Figure Hospitals Picture

Figure Clinics Picture

Figure Others Picture

Table Global Market Cancer Biologics Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Cancer Biologics Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Cancer Biologics Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Cancer Biologics Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Cancer Biologics Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Cancer Biologics Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Cancer Biologics Revenue (Million USD) and Growth Rate (2014-2024)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Cancer Biologics Type and Applications

Table Roche Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Cancer Biologics Type and Applications

Table Novartis Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Eli Lilly Basic Information, Manufacturing Base and Competitors

Table Eli Lilly Cancer Biologics Type and Applications

Table Eli Lilly Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Cancer Biologics Type and Applications

Table Sanofi Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Celgene Basic Information, Manufacturing Base and Competitors

Table Celgene Cancer Biologics Type and Applications

Table Celgene Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Cancer Biologics Type and Applications

Table Pfizer Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Bayer Basic Information, Manufacturing Base and Competitors

Table Bayer Cancer Biologics Type and Applications

Table Bayer Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Cancer Biologics Type and Applications

Table Johnson & Johnson Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors

Table Bristol-Myers Squibb Cancer Biologics Type and Applications

Table Bristol-Myers Squibb Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Cancer Biologics Type and Applications

Table Merck Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Cancer Biologics Type and Applications

Table Amgen Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

Table Global Cancer Biologics Revenue (Million USD) by Players (2014-2019)

Table Global Cancer Biologics Revenue Share by Players (2014-2019)

Figure Global Cancer Biologics Revenue Share by Players in 2017

Figure Global Cancer Biologics Revenue Share by Players in 2018

Figure Global Top 5 Players Cancer Biologics Revenue Market Share in 2018

Figure Global Top 10 Players Cancer Biologics Revenue Market Share in 2018

Figure Global Cancer Biologics Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Cancer Biologics Revenue (Million USD) by Regions (2014-2019)

Table Global Cancer Biologics Revenue Market Share by Regions (2014-2019)

Figure Global Cancer Biologics Revenue Market Share by Regions (2014-2019)

Figure Global Cancer Biologics Revenue Market Share by Regions in 2018

Figure North America Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Europe Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure South America Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Cancer Biologics Revenue and Growth Rate (2014-2019)

Table North America Cancer Biologics Revenue by Countries (2014-2019)

Table North America Cancer Biologics Revenue Market Share by Countries (2014-2019)

Figure North America Cancer Biologics Revenue Market Share by Countries (2014-2019)

Figure North America Cancer Biologics Revenue Market Share by Countries in 2018

Figure USA Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Canada Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Mexico Cancer Biologics Revenue and Growth Rate (2014-2019)

Table Europe Cancer Biologics Revenue (Million USD) by Countries (2014-2019)

Figure Europe Cancer Biologics Revenue Market Share by Countries (2014-2019)

Figure Europe Cancer Biologics Revenue Market Share by Countries in 2018

Figure Germany Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure UK Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure France Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Russia Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Italy Cancer Biologics Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Cancer Biologics Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Cancer Biologics Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Cancer Biologics Revenue Market Share by Countries in 2018

Figure China Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Japan Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Korea Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure India Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Cancer Biologics Revenue and Growth Rate (2014-2019)

Table South America Cancer Biologics Revenue by Countries (2014-2019)

Table South America Cancer Biologics Revenue Market Share by Countries (2014-2019)

Figure South America Cancer Biologics Revenue Market Share by Countries (2014-2019)

Figure South America Cancer Biologics Revenue Market Share by Countries in 2018

Figure Brazil Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Argentina Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Colombia Cancer Biologics Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Cancer Biologics Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Cancer Biologics Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Cancer Biologics Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Cancer Biologics Revenue Market Share by Countries in 2018

Figure Saudi Arabia Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure UAE Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Egypt Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure Nigeria Cancer Biologics Revenue and Growth Rate (2014-2019)

Figure South Africa Cancer Biologics Revenue and Growth Rate (2014-2019)

Table Global Cancer Biologics Revenue (Million USD) by Type (2014-2019)

Table Global Cancer Biologics Revenue Share by Type (2014-2019)

Figure Global Cancer Biologics Revenue Share by Type (2014-2019)

Figure Global Cancer Biologics Revenue Share by Type in 2018

Table Global Cancer Biologics Revenue Forecast by Type (2019-2024)

Figure Global Cancer Biologics Market Share Forecast by Type (2019-2024)

Figure Global Monoclonal Antibodies Revenue Growth Rate (2014-2019)

Figure Global Vaccines Revenue Growth Rate (2014-2019)

Figure Global Cell and Gene Therapy Revenue Growth Rate (2014-2019)

Figure Global Others Revenue Growth Rate (2014-2019)

Table Global Cancer Biologics Revenue by Application (2014-2019)

Table Global Cancer Biologics Revenue Share by Application (2014-2019)

Figure Global Cancer Biologics Revenue Share by Application (2014-2019)

Figure Global Cancer Biologics Revenue Share by Application in 2018

Table Global Cancer Biologics Revenue Forecast by Application (2019-2024)

Figure Global Cancer Biologics Market Share Forecast by Application (2019-2024)

Figure Global Hospitals Revenue Growth Rate (2014-2019)

Figure Global Clinics Revenue Growth Rate (2014-2019)

Figure Global Others Revenue Growth Rate (2014-2019)

Figure Global Cancer Biologics Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Cancer Biologics Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Cancer Biologics Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Cancer Biologics Revenue Market Forecast (2019-2024)

Figure Europe Cancer Biologics Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Cancer Biologics Revenue Market Forecast (2019-2024)

Figure South America Cancer Biologics Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Cancer Biologics Revenue Market Forecast (2019-2024)

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Roche

Novartis

Eli Lilly

Sanofi

Celgene

Pfizer

Bayer

Johnson & Johnson

Bristol-Myers Squibb

Merck

Amgen